Background: Phagocytosis, the process by which cells internalize particles, is essential for the defense of multicellular organisms against invading pathogens and is the major means by which many unicellular organisms obtain nutrients. The actin cytoskeleton plays a critical role in phagocytosis and the observation that a significant amount of force (10-20 nN) is generated during internalization, suggests that a myosin participates in the process. Although more than 15 distinct classes of myosin have been identified, their roles in phagocytosis are unknown.
Background
A variety of cell types can internalize particles either to obtain nutrients or to fight off host infection [1] . The phagocytic process can be divided into four discrete steps: particle binding to the plasma membrane; assembly of an actin-rich phagocytic cup that surrounds the particle; internalization of the particle; and degradation of the phagosome contents following trafficking along the endosomal-lysosomal pathway [1] [2] [3] [4] . The extension of the actin-rich phagocytic cup around a particle is probably driven largely by directed actin polymerization against the plasma membrane. The amount of force generated during the internalization event, 10-20 nN [2, 5] , is significant, suggesting that an actin-dependent motor protein, a myosin, provides the force necessary for the final act of particle engulfment. Two different types of myosin, myosin I and myosin II, have been localized to the phagocytic cup [6, 7] but neither is essential for phagocytosis [8, 9] , suggesting that another type of myosin might participate in this process.
The myosins are a superfamily of actin-based motor proteins found in organisms ranging from yeast to man. There are at least 14 different classes of unconventional myosin; these motor proteins have been implicated in diverse functions such as cytokinesis, cell migration, vesicle transport, endocytosis and hearing adaptation [10, 11] . Mutations in several unconventional myosins (myosins VI, VIIa and XV) result in deafness in mice and/or man [12] [13] [14] [15] [16] , but the functions of these myosins at the cellular level have yet to be determined.
The effects of myosin VIIa mutations on hearing have been most extensively studied because of the large number of available alleles in humans and mice [17, 18] . Some of the mutations must alter the enzymatic properties of the motor whereas others appear to result in a lowering of expression levels [19, 20] . A striking and as yet unexplained difference between the mouse model (known as shaker-1) and human patients with mutations in myosin VIIa is that the humans quite frequently have retinitis pigmentosa in addition to being deaf, a condition referred to as Usher's syndrome IB [17, 21] . Myosin VIIa is localized to the apical processes of the retinal pigment epithelia (RPE) in the eye [22] . This observation has prompted speculation that human myosin VIIa might play an integral role in the phagocytosis of shed rod outer segments because a failure in this process is known to result in retinitis pigmentosa [23] . A recent analysis of the function of cochlear inner and outer ear hair cells from shaker-1 mice provides some evidence that myosin VIIa plays a role in an endocytic process [24] . The inner and outer hair cells from the shaker-1 mice, unlike those from wild-type mice, do not internalize aminoglycosides. The precise mechanism by which the hair cells take up aminoglycosides is unknown, but the available evidence suggests that the defect lies in the internal trafficking pathway as clathrinmediated endocytosis appears to occur normally [24] . The inherent difficulties in analyzing protein function at the molecular level in hair cells of the mouse auditory system or the RPE of the affected human eye have made it difficult to unequivocally define the cellular role of myosin VIIa in endocytosis.
The Dictyostelium amoebae is a simple eukaryote that has a well characterized actin cytoskeleton and expresses a number of unconventional myosins [25] . The ability to target a gene of interest for deletion and a wide range of actin-based motile behaviors (such as fluid and particle uptake) that can be readily assayed following gene disruption make this organism uniquely suited for the investigation of unconventional myosin function. Although only class I, II and V myosins have been identified so far in this organism [25] , the existence of several uncharacterized myosin genes [26] suggests that additional classes of myosin might also be expressed. Here, it is reported that one of the previously uncharacterized Dictyostelium myosin genes, myoI, encodes myosin VIIa. When this gene was disrupted, a specific and significant defect in phagocytosis resulted, making this class of myosin a candidate either for providing the forces generated during phagocytosis or for the trafficking of phagosomes along the endosomal-lysosomal pathway.
Results and discussion
A partial clone of a previously uncharacterized Dictyostelium myosin gene, myoI, was used as a probe to isolate the full-length gene by screening several genomic and cDNA libraries. A series of overlapping clones were obtained and sequenced completely. Homology searches and phylogenetic analyses using the deduced amino-acid sequence of the motor domain, as well as the overall structure of the protein, revealed that myoI encodes a class VII myosin, hereafter referred to as DdMVII (Figure 1a) . The amino-terminal conserved myosin motor domain of DdMVII is attached to a long tail that begins with a short coiled-coil region, as in human and mouse myosin VIIA, but unlike the Caenorhabditis elegans myosin VII [27] [28] [29] . The coiled-coil region is followed by a tandem repeat of a MyTH4 (myosin tail homology 4) and a talin homology domain (Figure 1a ). The talin homology domain is also found in members of the band 4.1 superfamily and is believed to mediate membrane binding [11] . The function of the MyTH4 domain is unknown. Between the two MyTH4 and talin repeats lies a Src homology 3 (SH3) domain (Figure 1a ) that shows a high degree of homology to the SH3 domain of Dictyostelium Rho GTPase activating protein (GAP). The SH3 domain is lacking from C. elegans myosin VII [29] . The existence of the coiled-coil region and the SH3 domain in the DdMVII tail suggests that this myosin is a homologue of human and mouse myosin VIIa.
A Dictyostelium DdMVII null mutant was generated using standard gene-targeting techniques (Figure 1b,c) . The null mutant was tested in a series of assays to assess the function of its actin cytoskeleton. The behavior of the DdMVII null mutant was indistinguishable from control and wild-type strains in a number of assays. Disruption of myoI, a gene encoding a Dictyostelium class VII myosin. (a) The domain structure of DdMVII, the myoI gene product. Schematic representations of Dictyostelium DdMVII, human myosin VIIa and C. elegans HUM-6 heavy chain. Light gray, amino-terminal motor domain; narrow ovals, IQ motifs, which bind light chains. Unconventional myosin light chains are typically calmodulin or calmodulin-related proteins [11] ; C, predicted coiled-coil region; dark gray, the two MyTH4 domains MyTH4a and MyTH4b (the MyTH4a domain is discontinuous in the case of the human and C. elegans heavy chains); blue, the two talin domains; pink, the SH3 domain. Not indicated in the diagram of DdMVII are two brief proline-rich stretches in the carboxyl terminus, one preceding the MyTH4a domain and the other following the SH3 domain. (b) The myoI genomic locus. MYOI, the myoI coding region; wavy lines, the extragenic 5′ and 3′ regions; arrow, the direction of transcription; probe, segment of the myol gene used as a probe in Southern analysis; light gray box, the region of the myoI gene included in the pDTi7 plasmid; dark gray box labelled THY1, the thymidylate synthase selection marker; dashed lines, the region of the pDTi7 plasmid in which the THY1 gene was inserted to generate the gene disruption vector. When the DdMVII null mutant was incubated with either yeast or latex beads, a significant defect in particle uptake was observed ( Figure 3) . Cells of the null mutant ingested 80% fewer yeast particles than the control strain when assayed in suspension over the course of 90 minutes (Figure 3a ). The uptake of 1.5 µm latex beads ( Figure 3b ) and fluorescently labelled bacteria (data not shown) was similarly compromised. The phagocytosis defect was not because of a significant initial lag; the DdMVII null mutant exhibited a constant, yet slower rate of particle uptake throughout the course of the experiment (Figure 3b ). Given that the DdMVII null cells were found to be normal in all other aspects of actin-based cellular function tested, the results indicate that the observed phagocytic defect is neither because of loss of cytoskeletal integrity nor a generalized malfunction of the actin cytoskeleton. This differs from other known Dictyostelium phagocytic mutants in which decreases in particle uptake are concomitant with the loss of various other actin-dependent functions [30] [31] [32] [33] [34] [35] . The contrast between the DdMVII null mutant phenotype and that of other Dictyostelium mutants highlights the extraordinarily specific nature of DdMVII's involvement in phagocytosis.
Dictyostelium adsorbs a variety of microorganisms through a lectin-type receptor that binds terminal glucose and nonspecific, hydrophobic receptors [36] . Particle binding is the first step of phagocytosis, and alterations in cell-surface properties can result in decreased particle uptake [33, 36] . Defects in adhesion can be overcome by either performing the phagocytosis assay on a surface under conditions in which shear forces are zero or by using an 'adhesive' bacterium such as Salmonella minnesota R595 as the substrate [31, 33] . When the DdMVII null mutant was attached to a surface and incubated with an excess of yeast, it exhibited an approximately 80% decrease in particle uptake as compared with wild-type cells (Figure 4a ). This contrasts with what has been observed for the dysphagia-1 mutant, which exhibits a phagocytosis defect only when assayed in suspension [31] . Additionally, the DdMVII null mutant was incapable of growth in the adhesive R595 bacterium when it was provided as the sole food source (Figure 4b ). This
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Figure 2
The DdMVII null mutant exhibits normal pinocytic and exocytic activity. differs from the talin null mutant, for example, that has been shown to exhibit a phagocytosis defect because of alterations in the membrane-cytoskeleton interaction and yet can grow on R595 in suspension [33] . These result are consistent with the conclusion that DdMVII does not play a role in determining the cell-surface properties of Dictyostelium and, thus, the observed decrease in particle uptake is not a consequence of the loss of particle binding.
Loss of phagocytic activity can be correlated with the failure to form actin-filled phagocytic cups [31] . The DdMVII null mutant was capable of forming phagocytic cups. Both the control (Figure 5a,d) and DdMVII null cells (Figure 5b ,c,e,f) exhibited distinct, circular actinrich structures surrounding yeast particles. The DdMVII null mutants did not have any obvious alterations in the appearance of their phagocytic cups (Figure 5b ,c,e,f) that might be expected if DdMVII plays an important role in the formation of these structures. Therefore, it is likely that the decreased uptake of particles observed in the DdMVII null mutant is not because of an inability to form phagocytic cups.
It should be noted that there was not a complete loss of phagocytic activity in the DdMVII null mutant (Figures 3,4a ). This could be explained by the presence of another Dictyostelium myosin, the class I myosin myoB, which is known to be localized to phagocytic cups [7] . Deletion of myoB results in a small, but consistent decrease in particle uptake, around 20-30% lower than that observed for wild-type cells. It is possible that the residual 15-20% of phagocytic activity observed in the DdMVII null mutant is the result of the continued action of myoB. The creation of a myoB/MVII double mutant should allow us to test this possibility.
What is the role of DdMVII in phagocytosis? Given the presumed actin-based motor function of myosin VII, it is The phagocytic defect is not due to loss of particle adhesion. 
Control
DdMVII null mutant reasonable to assume that any actin-dependent aspect of phagocytosis is a potential point at which DdMVII might act. There are three steps at which actin participates in particle uptake ( Figure 6 ). The first is the extension of the phagocytic cup but, as the actin-driven extension of the plasma membrane is probably a polymerization-based event, it is unlikely that DdMVII is required for this process. Consistent with this conclusion is the observation that the DdMVII null cells were capable of making phagocytic cups ( Figure 5 ). Next, actin is required during the internalization of the particle [2] . Once the phagocytic cup is almost completely formed, the cell generates a significant amount of force concomitant with particle internalization. The amount of force generated, 10-20 nN [2] , and the actin-dependence of phagocytosis suggest that a myosin plays a role in this process. An attractive model for DdMVII function is that it generates the forces required for particle engulfment, provided that there are sufficient numbers of myosin VII molecules present. This could be either by pulling on the actin filaments attached to the nascent phagosomes or by being involved in the closure of the phagocytic cup through a pursestring mechanism [5] . Finally, the third actin-dependent process might be in trafficking along the endosomal-lysosomal pathway. The involvement of the actin cytoskeleton in the movement of phagosomes along the degradation pathway is unknown. The available evidence suggests that these movements are largely microtubule dependent [37] . Evidence indicating a role for actin and a myosin in the late stages of endosomal processing is emerging [38] [39] [40] [41] and, thus, it is not unreasonable to speculate that more than one type of myosin might be involved. This is a possibility that needs to be explored in greater detail. Nevertheless, the observation that there is neither a pinocytic nor an exocytic defect in the DdMVII null mutant (Figure 2) indicates that DdMVII does not have a general role in the trafficking of vesicles along the endosomal-lysosomal processing pathway and might not be required for phagosome maturation. A comprehensive analysis of the DdMVII null mutant will be necessary to establish clearly the step in phagocytosis that requires DdMVII.
Dictyostelium is the first lower eukaryote found to express a homologue of human and mouse myosin VIIa. The molecular genetic tools available in this organism will now enable a systematic analysis of the various myosin VII tail domains for which roles have yet to be determined; for example, MyTH4 domains are found in several classes of myosin (classes VII, X and XV) as well as in a plant kinesin, yet little is known about their function [11, 15, 42] . The effect of the deletion of one or both of the DdMVII MyTH4 domains on the function of this myosin can now be examined directly through complementation experiments. Additionally, the effect of several of the missense mutations identified in patients with Usher's syndrome that occur in conserved residues of the myosin VIIa head or tail on the function, localization and stability of the mutant myosin could be readily analyzed. Such studies could provide basic information about the functionally important domains of myosin VIIa and insight into the means by which various mutations result in deafness in mice and humans.
Conclusions
The Dictyostelium homologue of human and mouse myosin VIIa plays a specific and important role in phagocytosis. The presence of this myosin in a lower eukaryote and the identification of substantial endocytic defects in both the Dictyostelium and mice myosin VII mutants suggest that its role in endocytosis might have been conserved during evolution.
Materials and methods

Cloning and characterization of the myoI gene
All manipulation of DNA and RNA, including northern and Southern blotting, was carried out using standard techniques [43] . A 450 bp myoI PCR product [26] was used to screen a 4 h λgt11 cDNA library (kind gift of Peter Devreotes, Johns Hopkins University), and a series of clones encompassing the 5′ end of the myoI gene obtained. A 3.5 kb cDNA clone derived from random sequencing of a 16-18 hr cDNA library that mapped to the myoI locus was identified by William Loomis, UCSD, La Jolla, CA (personal communication) and used to re-screen the same library to obtain the full 3′ end of the myoI gene. The clones were either sequenced manually using the Sequenase system, (Amersham Pharmacia Biotech) or using an automated sequencer (Applied Biosystems) using a series of custom oligonucleotides as primers. Sequences were read into a computer and analyzed using Lasergene Research Paper A class VII unconventional myosin is required for phagocytosis Titus 1301 software and equipment (DNAStar). The Genbank accession number for the myoI sequence is L35321. Phylogenetic classification of DdMVII was determined by a combination of sequence analysis, comparison to the GenBank database using the BLAST algorithm [44] at the National Center for Biotechnology Information BLAST server, and ClustalW [45] .
Generation of the DdMVII null strains
The myoI disruption plasmid was created by inserting the 2.1 kb THY1 selection cassette into the BglII site of the pDTi7 plasmid (a cDNA clone encompassing nucleotides 19-2613 of the 5′ region of the myoI gene). The resultant plasmid, pDTi12, was digested with EcoRI to liberate the gene replacement fragment from the plasmid backbone, and the total digest introduced into the thymidine auxotrophic strain JH10 [46] by electroporation [47, 48] . Individual transformants were selected for by growth in the absence of thymidine. A total of 20 individual transformants were isolated and grown to confluence in individual 100 mm Petri dishes. DNA was prepared from each individual clone [49] and analyzed for disruption of the myoI gene by Southern blotting. Clones from several independent transformations were analyzed and found to have identical behaviors. Several individual transformants that were able to grow without the addition of exogenous thymidine but did not prove to have a disrupted myoI locus, as determined by Southern analysis, were considered non-homologous recombinants and used as control strains in all experiments. The detailed analysis of only one of each of these strains, a single control and myoI -mutant (strain number HTD15-3), which is representative of all other cell lines, is presented here.
Functional assays
Phagocytosis, pinocytosis and exocytosis assays of cells in suspension were performed using standard methods [32, 36, 40, 50] . Microscopic analysis of phagocytosis was carried out by first allowing 1.5 × 10 5 cells in starvation buffer to attach to a 2 mm acid-washed round coverslip for 30 min. The buffer was aspirated, a 10-fold excess of heat-killed yeast added, and the cells incubated for 30 min. The excess liquid was aspirated and the cells immediately fixed with picric acid and paraformaldehyde, then postfixed with 70% ethanol [51] . The number of yeast per Dictyostelium was determined by manual counting using phase contrast microscopy. At least ten randomly selected fields were analyzed. F-actin localization was visualized using rhodamine-phalloidin (Molecular Probes) using the fixation method described above.
